Callan Family Office’s CorVel CRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.35M Buy
61,267
+18,114
+42% +$1.04M 0.08% 252
2025
Q4
$2.92M Sell
43,153
-5,919
-12% -$429K 0.06% 270
2025
Q3
$3.8M Sell
49,072
-2,380
-5% -$212K 0.12% 176
2025
Q2
$5.29M Buy
51,452
+47,169
+1,101% +$5.2M 0.17% 141
2025
Q1
$480K Sell
4,283
-3,670
-46% -$410K 0.04% 334
2024
Q4
$885K Buy
7,953
+5,331
+203% +$597K 0.06% 275
2024
Q3
$286K Buy
+2,622
New +$262K 0.05% 144

Other funds holding CRVL

Callan Family Office's CRVL Position: Q1 2026 in Review

Callan Family Office increased its CorVel (CRVL) stake by 42% in Q1 2026, buying an estimated $1.04M and bringing the position to 61,267 shares worth $3.35M. The position accounts for 0.08% of the portfolio, ranked #252.

Callan Family Office first reported a position in CRVL in Q3 2024 and has held it in 7 quarters since. The position peaked at $5.29M in Q2 2025. 281 funds tracked by Wall St. Rank hold CRVL as of Q1 2026.

  • Callan Family Office held 61,267 shares of CorVel worth $3.35M as of Q1 2026.
  • Callan Family Office bought 18,114 CorVel shares in Q1 2026, an estimated $1.04M.
  • CorVel made up 0.08% of Callan Family Office's portfolio in Q1 2026, its #252 holding.
  • Callan Family Office first reported a position in CorVel in Q3 2024 and has held it in 7 quarters since.
  • Callan Family Office's CorVel position peaked at $5.29M in Q2 2025.
  • 281 funds tracked by Wall St. Rank held CorVel as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.